| 摘要 |
<p>The present invention relates to a method of treating gastrointestinal stromal tumors (GIST) especially GIST which is progressing after imatinib therapy or after imatinib and sunitinib therapy using a combination comprising (a) a c kit inhibitor and (b) a dual KIT inhibitor and FGFR inhibitor or FGFR inhibitor.</p> |
